je.st
news
Tag: issues
U.S. DOT Issues Emergency Testing Order for Transport of Crude Oils
2014-03-01 05:00:00| Industrial Newsroom - All News for Today
Grabner Instruments MINIVAP VPXpert Meets Need for Reliable Vapor Pressure Testing of Crude Oil<br /> <br /> Vienna, Austria – The US Department of Transportation (DOT) has issued an Emergency Testing Order that requires all shippers to test crude oil from the Bakken region to ensure the proper identification of the crude oil before it is transported by rail. The Emergency Testing Order is in response to a number of recent incidents involving the derailment of trains transporting crude ...This story is related to the following:Test and Measuring InstrumentsSearch for suppliers of: Oil Testers | Testing Instruments
Tags: order
issues
transport
testing
Warehouse job issues debated
2014-03-01 03:42:36| Logistics - Topix.net
John Husing of Economics & Pollitics, Inc., left, speaks during a panel discussion on the economic benefit of distribution jobs on Thursday, Feb. 27, 2014 at Riverside City Hall.
Tags: issues
job
warehouse
debated
CHMP Issues Positive Opinion for Tablet Formulation of Merck's NOXAFIL
2014-03-01 00:42:42| Biotech - Topix.net
Merck , known as MSD outside the United States and Canada, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency recipients with graft-versus-host disease or those with hematologic malignancies with prolonged neutropenia from chemotherapy.
Tags: issues
positive
opinion
formulation
CHMP Issues Positive Opinion for Tablet Formulation of Mercks NOXAFIL (posaconazole)
2014-02-28 14:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of a new, investigational tablet formulation of NOXAFIL (posaconazole). Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558orRobert Consalvo, 908-423-6595orInvestor:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: issues
positive
opinion
formulation
FDA Issues Proposed Ruling on Labeling Requirements
2014-02-28 09:00:00| Expeditors Newsflash - Americas Edition
Expeditors Newsflash - Americas Edition
Tags: issues
requirements
proposed
ruling
Sites : [354] [355] [356] [357] [358] [359] [360] [361] [362] [363] [364] [365] [366] [367] [368] [369] [370] [371] [372] [373] next »